Buell Jennifer — SEC Form 4 filings
SEC reporting owner CIK 1711184. 19 Form 4 filings on record with FilingPulse; latest filed 2026-08-07.
Transaction summary — filings shown
Covers all 19 filings on record, filed 2024-01-18 to 2026-08-07. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 23.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| AGENUS INC (AGEN) | See Remarks, Director | 13 | — | — | 14 |
| MiNK Therapeutics, Inc. (INKT) | Chief Executive Officer | 5 | — | — | 8 |
| Protagenic Therapeutics, Inc.\new (PTIX) | Director | 1 | — | — | 1 |
Form 4 filings — Buell Jennifer
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-07 | 4 | AGENUS INC (AGEN) | Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
| 2026-04-28 | 4 | AGENUS INC (AGEN) | Grant/award (A): 300,000 (derivative) @ $0 · Grant/award (A): 5,000 (derivative) @ $0 | EDGAR |
| 2026-01-14 | 4/A | MiNK Therapeutics, Inc. (INKT) | Tax withholding (F): 10,024 @ $11.12 | EDGAR |
| 2026-01-06 | 4 | MiNK Therapeutics, Inc. (INKT) | Grant/award (A): 31,474 @ $11.12 · Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2025-10-03 | 4/A | MiNK Therapeutics, Inc. (INKT) | Tax withholding (F): 5,351 @ $15.36 | EDGAR |
| 2025-09-11 | 4 | MiNK Therapeutics, Inc. (INKT) | Grant/award (A): 18,229 @ $15.36 · Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2025-05-06 | 4 | AGENUS INC (AGEN) | Grant/award (A): 581 @ $3.11 | EDGAR |
| 2025-05-05 | 4 | AGENUS INC (AGEN) | Grant/award (A): 869 @ $2.08 | EDGAR |
| 2025-04-10 | 4 | AGENUS INC (AGEN) | Grant/award (A): 1,159 @ $1.56 | EDGAR |
| 2025-03-27 | 4 | AGENUS INC (AGEN) | Grant/award (A): 1,123 @ $1.61 | EDGAR |
| 2025-03-24 | 4 | AGENUS INC (AGEN) | Grant/award (A): 409 @ $2.35 | EDGAR |
| 2025-03-11 | 4 | AGENUS INC (AGEN) | Grant/award (A): 545 @ $3.32 | EDGAR |
| 2025-03-05 | 4 | AGENUS INC (AGEN) | Grant/award (A): 626 @ $3.32 | EDGAR |
| 2025-02-18 | 4 | AGENUS INC (AGEN) | Grant/award (A): 516 @ $3.50 | EDGAR |
| 2025-02-04 | 4 | AGENUS INC (AGEN) | Tax withholding (F): 270 @ $3.57 | EDGAR |
| 2025-01-28 | 4 | AGENUS INC (AGEN) | Grant/award (A): 776 @ $3.57 | EDGAR |
| 2024-11-18 | 4 | AGENUS INC (AGEN) | Grant/award (A): 300,000 (derivative) @ $0 | EDGAR |
| 2024-03-29 | 4 | Protagenic Therapeutics, Inc.\new (PTIX) | Grant/award (A): 75,000 (derivative) @ $1.74 | EDGAR |
| 2024-01-18 | 4 | MiNK Therapeutics, Inc. (INKT) | Grant/award (A): 500,000 (derivative) @ $0 · Grant/award (A): 660,919 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1711184 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →